Artelo Biosciences Inc
ARTL - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$589.11K
Close$
$-0.30
115.2% downside
Current Fair Value
115.2% downsideOvervalued by 115.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $589,106.00 |
|---|---|
| Enterprise Value | $-3,559,894.00 |
| Earnings per Share | $-49.23 |
| Beta | -0.07 |
| Outstanding Shares | 301,333 |
Return
| Return on Equity | -253.57% |
|---|---|
| Return on Assets | -196.18% |
| Return on Invested Capital | -240.87% |
Valuation & Multiples
| P/E Ratio | -0.03 |
|---|---|
| PEG | 0.1 |
| Price to Sales | - |
| Price to Book Ratio | 0.12 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.21 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-6.48
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 17, 2026
EPS Estimate
$-7.02
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.32%▼ 1.85% |
|---|---|
| Total Invested | $131,972▼ 61.82% |
| Investors Holding | 100% |
About Artelo Biosciences Inc
3 employees
Artelo Biosciences, Inc. is a San Diego-based biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting lipid signaling pathways including the endocannabinoid system. Artelo is rap...